Fresenius Medical Care AG (FMCQF) EBITDA Margin (2009 - 2026)
Fresenius Medical Care AG (FMCQF) posted quarterly EBITDA Margin of 6.21% for Q1 2026, up 455.0% year-over-year from 1.12% in Q1 2025, and down 67.47% quarter-over-quarter from 19.07% in Q4 2025.
Fresenius Medical Care AG (FMCQF) EBITDA Margin (2009 - 2026) Analysis & Trends
Fresenius Medical Care AG's EBITDA Margin history runs 18 years deep, the most recent figure standing at 6.21% for Q1 2026.
- In Q1 2026, EBITDA Margin rose 455.0% year-over-year to 6.21%; the TTM figure through Mar 2026 stood at 13.03% (up 476.0% YoY), while the FY2025 annual figure was 19.04%, up 157.0% from the prior year.
- EBITDA Margin for Q1 2026 stood at 6.21%, down from 19.07% in the prior quarter.
- The five-year high for EBITDA Margin was 23.86% in Q3 2022, with the low at 1.34% in Q4 2023.
- The 5-year median for EBITDA Margin is 16.72% (2025), against an average of 13.01%.
- The sharpest annual moves came in 2022 and 2023: EBITDA Margin surged 1643 bps in 2022, then plunged 2280 bps in 2023.
- Fresenius Medical Care AG's EBITDA Margin stood at 21.46% in 2022, then tumbled by 106 bps to 1.34% in 2023, then soared by 1178 bps to 14.47% in 2024, then soared by 32 bps to 19.07% in 2025, then plunged by 67 bps to 6.21% in 2026.
- Business Quant data shows FMCQF's EBITDA Margin at 6.21% in Q1 2026, 19.07% in Q4 2025, and 9.75% in Q3 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.58% |
| Mar 31, 2026 | 6.21% |
| Dec 31, 2025 | 19.07% |
| Sep 30, 2025 | 9.75% |
| Jun 30, 2025 | 16.72% |
| Mar 31, 2025 | 1.66% |
| Dec 31, 2024 | 14.47% |
| Sep 30, 2024 | -0.27% |
| Jun 30, 2024 | 17.04% |
| Mar 31, 2024 | 0.30% |
| Dec 31, 2023 | -1.34% |
| Sep 30, 2023 | 15.76% |
| Jun 30, 2023 | 20.66% |
| Mar 31, 2023 | 18.83% |
| Dec 31, 2022 | 21.46% |
| Sep 30, 2022 | 23.86% |
| Jun 30, 2022 | 20.17% |
| Mar 31, 2022 | 16.86% |
| Dec 31, 2021 | 5.03% |
| Sep 30, 2021 | 25.69% |